Back to TEVA Stock Lookup
Pages: 1 2 3 4 5 6 »» Last Page

TEVA Related Analyst Ratings

May 9, 2013 05:43 PM BMO Capital Starts Teva Pharma (TEVA) at Outperform
Mar 18, 2013 07:58 AM Wells Fargo Downgrades Teva Pharma (TEVA) to Market Perform
Feb 25, 2013 08:02 AM Argus Downgrades Teva Pharma (TEVA) to Hold
Feb 12, 2013 01:15 PM Bristol-Myers' Baraclude News Could Be Positive for Teva Pharma (TEVA) - Analyst
Feb 8, 2013 07:17 AM Canaccord Genuity Downgrades Teva Pharma (TEVA) to Hold
Dec 12, 2012 02:26 PM Investors Scoff At Teva's (TEVA) Cost Cutting Plans
Dec 12, 2012 07:55 AM Leerink Swann Downgrades Teva Pharma (TEVA) to Market Perform
Dec 10, 2012 09:30 AM Investor Meeting is Potential Catalyst for Teva (TEVA)
Dec 3, 2012 11:14 AM Teva Pharma (TEVA) Investors Look To Analyst Day
Dec 3, 2012 06:41 AM UBS Downgrades Teva Pharma (TEVA) to Neutral
Nov 30, 2012 01:18 PM Buckingham Research Downgrades Teva Pharma (TEVA) to Neutral
Oct 16, 2012 12:54 PM Canaccord Genuity Cuts Price Target on Teva (TEVA)
Oct 1, 2012 06:22 AM Investors Focus on Shire (SHPG) as Generic Adderall XR Unlikely This Year
Sep 18, 2012 09:45 AM Guggenheim Starts Teva Pharma (TEVA) at Neutral
Sep 12, 2012 09:23 AM Leerink Swann Maintains an 'Outperform' on Teva Pharma (TEVA); Review with Patent Specialist
Sep 10, 2012 08:46 AM Needham & Company Maintains a 'Buy' on Sagent Pharmaceuticals (SGNT); Getting Some Mojo Back
Sep 10, 2012 08:43 AM Needham & Company Maintains a 'Strong Buy' on Mylan (MYL); Detrol LA Settlement Provides Small Dose of Certainty
Aug 24, 2012 08:05 AM Needham & Company Maintains a 'Hold' on Par Pharmaceutical (PRX); Is Endo (ENDP) the 'Mystery Bidder'
Aug 23, 2012 09:17 AM Canaccord Genuity on Life Sciences/Pharmaceutical: Catalysts to Push TEVA and IPXL Higher in 2H
Aug 3, 2012 01:45 PM Oppenheimer Maintains a 'Perform' on Teva Pharma (TEVA); Wait for Clarity on Pipeline
Aug 3, 2012 10:33 AM Canaccord Genuity Maintains a 'Buy' on Teva Pharma (TEVA); A Little Reaction or Side Effect?
Aug 3, 2012 09:45 AM Needham & Company Maintains a 'Hold' on Teva Pharma (TEVA); European Generics Are Bottoming & Downside Risks Shrink
Jul 20, 2012 08:31 AM Needham & Company maintains a 'Strong Buy' on Mylan (MYL); PRX Grossly Undervalued by TGP, MYL/PRX Instead As Strong Combo
Jun 26, 2012 11:05 AM UBS Defends Momenta Pharmaceuticals (NASDAQ: MNTA); Negative News Largely In Stock
Jun 25, 2012 12:46 PM UBS Maintains a 'Buy' on Teva Pharma (TEVA); The Decision's In
Jun 25, 2012 09:56 AM Canaccord Genuity on Life Sciences: Generic Adderall XR Approval Offers Several Cross-stock Implications
Jun 25, 2012 09:01 AM Canaccord Genuity Reiterates a 'Buy' on Teva Pharma (TEVA); Win Now A Reality
Jun 21, 2012 10:53 AM Canaccord Genuity on Life Sciences/Specialty Pharma: Top Summer Catalyst-Driven Ideas To Trump 'Macro' Influence
Jun 19, 2012 03:48 PM Barclays on U.S. Specialty Pharmaceuticals: Muddling Now, but Opportunity Remains
Jun 19, 2012 07:12 AM Goldman Sachs Adds Watson Pharmaceuticals (WPI) to Conviction Buy List, Cheap Vs. Peers
Jun 18, 2012 08:36 AM Deutsche Bank Revists The Story on Teva Pharma (TEVA); Many Catalysts Ahead, Floor Established at $35
Jun 15, 2012 08:26 AM Canaccord Genuity Reiterates a 'Buy' on Teva Pharma (TEVA); Top-Line Phase III Results From GALA Study
Jun 12, 2012 08:59 AM Canaccord Genuity Maintains a 'Buy' on Teva Pharma (TEVA); Vision Becoming More Clear After Meeting W/ CEO
May 30, 2012 07:36 AM Needham & Company maintains a 'Strong Buy' on Par Pharmaceutical (PRX); Defending Core Fundamentals Despite Setback From Lovaza Litigation
May 29, 2012 08:24 AM Canaccord Genuity Reiterates a 'Buy' on Momenta Pharmaceuticals (MNTA); Copaxone Preview
May 25, 2012 01:21 PM Barclays Maintains an 'Equalweight' on Teva Pharma (TEVA); Adjusting Estimates After Business Update
May 25, 2012 10:52 AM UBS Maintains a 'Buy' on Teva Pharma (TEVA); CEO Highlights From Conference Call
May 25, 2012 09:39 AM Canaccord Genuity Maintains a 'Buy' on Teva Pharma (TEVA); Adjusting Estimates; Copaxone Still In Focus
May 25, 2012 07:55 AM Needham & Company Maintains a 'Hold' on Teva Pharma (TEVA); Adjusting Estimates
May 23, 2012 12:46 PM UPDATE: Auriga Starts Teva Pharma (TEVA) at Hold; Sidelined Until New CEO Is Convincing
May 21, 2012 10:05 AM Canaccord Genuity on Pharmaceuticals: Generic Valuation at Historical Trough Level Ahead of Meetings
May 17, 2012 02:44 PM Auriga Reiterates a 'Buy' on Spectrum Pharmaceuticals (SPPI); Generic Leucovorin Shortage Continues
May 11, 2012 01:26 PM Barclays on Healthcare: Top Takeaways from our Second Annual Therapeutics Symposium
May 10, 2012 11:11 AM Canaccord Genuity on Specialty Pharma: TEVA's Q1 Effect on Specialty Pharma (TEVA, WPI, PRGO & MYL)
May 10, 2012 08:32 AM Needham & Company Upgrades Teva Pharma (TEVA) to Hold; Same Old Growth Drags and Risk Overhangs
May 4, 2012 11:42 AM Canaccord Genuity Reiterates a 'Buy' on Momenta Pharmaceuticals (MNTA); Focus Moves to Copaxone Trial
May 1, 2012 02:39 PM Cantor Fitzgerald Maintains a 'Buy' on Warner Chilcott (WCRX); Let's Make It Official
Apr 26, 2012 10:42 AM UPDATE - Auriga Initiates Coverage on Forest Laboratories (FRX); Lack of Near Term Catalysts Keep Us Sidelined
Apr 19, 2012 10:07 AM Canaccord Genuity on Specialty Pharmaceutical: Top Picks Have Less Volatility With Earnings
Apr 9, 2012 02:10 PM Barclays on U.S. Specialty Pharmaceuticals: Model Adjustments on MYL, PRX, TEVA, & WCRX
Pages: 1 2 3 4 5 6 »» Last Page

Back to TEVA Stock Lookup